Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company pioneering RNA interference (RNAi) therapeutics, a gene-silencing approach designed to treat disease by disabling genes that cause or contribute to it. The company discovers, develops, and commercializes medicines based on RNAi, including approved therapies and a pipeline of investigational treatments. Its research targets both rare and prevalent diseases, with a mission to bring innovative medicines to patients.
Recently Posted Jobs at Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.
Typical time on-site:
United States
